Bioorganic and Medicinal Chemistry Letters p. 3052 - 3059 (2016)
Update date:2022-08-11
Topics:
Zou, Yi
Xiao, Jianhu
Tu, Zhengchao
Zhang, Yingyi
Yao, Kun
Luo, Minghao
Ding, Ke
Zhang, Yihua
Lai, Yisheng
A series of novel 4,5,6-trisubstituted pyrimidines were designed as potent covalent Bruton's tyrosine kinase (BTK) inhibitors based on the structure of ibrutinib by using a ring-opening strategy. Among these derivatives, compound I1 exhibited the most potent inhibitory activity with an IC50 value of 0.07 μM. The preliminary structure-activity relationship was discussed and the primary amino group at the C-4 position of pyrimidine was crucial for maintaining BTK activity. Furthermore, molecular dynamics simulations and binding free energy calculations were performed for three inhibitor-BTK complexes to determine the probable binding model, which provided a comprehensive guide for further structural modification and optimization.
View MoreContact:18710867521(wechat)
Address:Rm10516,Galaxy Tech Building #2,No.25 Tangyan Rd,Hi-Tech Zone,Xi'an, China
Jiangsu Chunjiang AgroChemical Co.,Ltd.
Contact:+86-13817348163
Address:Panjiawan 84, Zhixi Town, Jintan City, China
Contact:+86-574-87642758
Address:Room 901, Yinyi Bund Building, 132 Renmin Road
ClickChem Technology Co., Limited
Contact:+86-0310-6519966/0531-52893837
Address:No.750 Shunhua Road, High-Tech Zone, Jinan city, Shandong China
Shouguang Nuomeng Chemical Co., Ltd.
Contact:+86-536-5119508/18363669993
Address:Hou Zhen Industrial Park, Shouguang, Shandong, China
Doi:10.1246/bcsj.20140378
(2015)Doi:10.1016/j.molstruc.2005.06.021
(2005)Doi:10.1134/S0036024416030262
(2016)Doi:10.1103/PhysRevB.33.6326
()Doi:10.1021/jm101577z
(2011)Doi:10.1071/CH11060
(2011)